mRNA Conference USA 2026
|
view program
Discover the highlights of the event
connect with us
Get your questions answered by our team
become a partner
Join as a sponsor and reserve your booth
Meet Our Featured Speakers
Kok-Seong Lim
Independent Consultant
Shyam Kumar Gudey
Independent Consultant
Kok-Seong Lim
Independent Consultant
Craig Martin
University of Massachusetts
GLOBAL FORUM FOR MRNA-BASED THERAPEUTICS AND DRUG DEVELOPMENT
Welcome to mRNA Conference USA 2026, where global pharmaceutical and biotech leaders join industry experts to explore breakthroughs in mRNA therapeutics for vaccines, personalized medicine, and beyond.
The event explores the role of mRNA technology in developing novel treatments, covering the full spectrum from R&D to clinical trials, large-scale manufacturing, and commercialization. It highlights advancements in RNA modification, therapeutic delivery systems, and vaccine development, and showcases the latest progress in mRNA, siRNA, and miRNA-based therapeutics.
Join us to explore next-generation mRNA therapeutics, gain valuable insights, and connect with peers to help shape the future of medicine.
key topics for
Future of mRNA-based therapeutics for infectious diseases and beyond
Explore the potential of mRNA therapeutics as a transformative new class of drugs.
Breakthrough research in mRNA, siRNA, and miRNA-based therapeutics
Gain insights into how advancements in mRNA, siRNA, and miRNA are shaping the future of therapeutic applications.
Challenges in scaling mRNA vaccines manufacturing for global distribution
Analyze advanced methods for the rapid development and large-scale distribution of vaccines in response to pandemics.
Latest advancements in mRNA formulation and delivery technologies
Discover the latest advancements in therapeutic mRNA delivery as they progress from the laboratory to patient treatment.
AI and ML-driven approaches to enhance mRNA therapeutic design
Learn how advanced AI and machine learning algorithms, combined with data analytics, are accelerating therapeutic design and revealing new insights.
Regulatory and compliance considerations in mRNA clinical development
Understand key regulatory and compliance considerations for the approval of mRNA therapeutics.
INDUSTRY TOPICS
NETWORKING EVENTS
LEADING EXPERTS
Q&A SESSIONS
Latest News
INVESTMENT
12 Jan 2026
A New Pulse in Biotech IPOs Starts With OncologyTECHNOLOGY
7 Jan 2026
Can Generative AI Crack the Code of mRNA Design?RESEARCH
19 Dec 2025
A New Twist Makes mRNA Drugs More SelectiveREGULATORY
18 Dec 2025
BARDA Pullback Signals New Phase for US mRNA Development
mRNA Design Enters a More Predictive Era
INNOVATION
17 Dec 2025
New AI research forecasts mRNA protein output earlier, helping developers refine drug designs before costly lab testing begins
they've attended our events
Expert Speakers
Hongfeng Deng
Sanofi
Brett Hill
Arcturus Therapeutics
Daniel Dixon
TriLink BioTechnologies
Past Attendees
Sanofi
28 Capital
Mayo Clinic
Arcturus Therapeutics
Crafton Biotechnology
Tessera Therapeutics
TriLink BioTechnologies
Standard BioTools
University of Michigan
hidden text
subscribe for updates
hidden text
our sponsors
